STI Stock Trade Intelligence
ENP

Entropy Neurodynamics Ltd

Health Care · ASX:ENP
$0.0390
▼ -4.88%
Market cap
$64M
Turnover
$82,500
Last price
$0.0390
Day change
-4.88%
Announcements
18
Range, past year
Open 0.033 · Low 0.025 · Now 0.039 · High 0.043
Open ENP in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

ENP momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-09-28.
Momentum quality
47/100
Wyckoff phase
Distribution28d
Trend stage
Neutral
1 Day
-4.9%
1 Week
-2.5%
1 Month
-4.9%
RSI
46
Avg daily range
4.5%

Entropy Neurodynamics Ltd scores 47 out of 100 for momentum quality, a reading rated low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.

On the Wyckoff cycle it sits in Distribution, where it has been for 28 trading days. The weekly timeframe reads Uptrend, which does not yet agree with the daily view.

Against the wider market it is currently matching and the institutional accumulation signal reads low.

What stands out
  • Trend R² 0.81 — highly linear uptrend
  • Above SMA50 for 60 days
Points to watch
  • Thin liquidity
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

ENP announcements

Recent price-sensitive releases.
  • 2026-09-14 All Patients Improve, 50% Achieve 12-Week BED Remission Progress Report
  • 2026-08-28 Appendix 4E and 2026 Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
  • 2026-08-26 Entropy Advances TRP-8803 to US Phase 2 in Depression Web Cast | Trading Halt Lifted | Progress Report
  • 2026-08-24 Trading Halt Trading Halt
  • 2026-08-19 TRP 8803 manufacturing secured for Phase 2/3 advancement Progress Report
  • 2026-08-04 72-Patient Trial Fast-Tracks TRP-8803 Commercialisation Trading Halt Lifted | Progress Report
  • 2026-07-31 Trading Halt Trading Halt
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.